// App-Quantinova.ai

AEP600 : Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations

Researchers

Presenter

  • Pedro Marques

Principal Investigators

  • Daniela Magalhaes

  • Francisca Caimari

  • Laura Hernndez Ramrez

  • David Collier

  • Chung Lim

  • Karen Stals

  • Sian Ellard

  • Maralyn Druce

  • Scott Akker

  • Mona Waterhouse

  • William Drake

  • Ashley B. Grossman

  • Marta Korbonits

Medical Centers

  • William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Centre for Experimental Medicine & Rheumatology, London, United Kingdom

  • Centro Hospitalar Universitário São João, Porto, Portugal, Department of Endocrinology, Diabetes and Metabolism, Portugal

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). Bethesda MD, USA, Section on Endocrinology & Genetics, Bethesda, United States

  • Royal Devon and Exeter NHS Foundation Trust, Exeter, UK, Department of Molecular Genetics, Exeter, United Kingdom

  • St. Bartholomew´s Hospital, West Smithfield, London, UK, Department of Endocrinology, London, United Kingdom

Locations

  • United Kingdom

  • Portugal

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Pituitary adenomas

  • Familial multiple endocrine neoplasia type I

  • Gastrointestinal defects and immunodeficiency syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A